glp-1 drugs for type 2 diabetes What to Make of the Coverage and Cost Landscape Upcoming wave of hormone-based therapies
Description
What is the FDA-approved use of Zepbound
Pediatric obesity and MASLD present significant long-term health risks, making early intervention crucial
Orforglipron was discovered by Chugai Pharmaceutical and licensed by Lilly in 2018
The Emax values for 12 GLP-1RA drugs ranged from 4.25 kg to 22.6 kg, with Retatrutide exhibiting the highest Emax value and Liraglutide the lowest
Further research is needed
Association between GLP-1 receptor gene polymorphisms with reward learning, anhedonia and depression diagnosis
